HPS Pharmacies’ lecture series is an integral part of the professional services provided to our client’s facilities. The HPS Pharmacies lecture series program offers in-service educational programs covering topics such as new medicines, side-effects, adverse reactions to medicines and other relevant issues. The program assists in keeping nursing and medical staff abreast of current trends in pharmaceutical care. This annual program offers a minimum of twelve lectures, with at least one released at the beginning of every month. Additional lectures are also released throughout the year in response to developing issues.
The topics are selected based on feedback received from clients, and integrated with a needs analysis conducted by the visiting clinical pharmacists. The lectures are written by one of HPS’ pharmacists with specialist knowledge on the topic. The completed lecture, along with further reading, is made available to all HPS pharmacists to present to their clients.
Your visiting HPS pharmacist can assist in tailoring a lecture program suitable for your facility; including lectures which may be required on a particular topic not covered by the current program. Attending staff are provided with handouts that include a self-assessment tool to assist the learning process, and may be used to contribute toward their ‘Continuing Professional Education’ (CPE).
Each lecture can also be adapted to suit any audience or group size. HPS offers a range of presentation styles from a brief presentation to an in-depth discussion for staff, and can adapt material for participants who may not have a medical background.
For further information regarding HPS’ comprehensive lecture series, please speak to your visiting HPS Pharmacist, or contact the Regional Operations Manager in your state.
The diverse schedule for the 2020 HPS Lecture Series seen below can be downloaded, along with a full list of alternative topics, via this link.
HPS Lecture Series Program 2020
|Available From||Topic Summary|
|1st January||Euglycaemic ketoacidosis associated with SGLT2 inhibitor use in the perioperative period|
|1st February||Safe use of high-risk medications (APINCHS)|
|1st March||Hormonal therapy in breast cancer|
|1st April||Medication options for analgesia|
|1st May||Total Parenteral Nutrition|
|1st June||Gestational diabetes|
|1st July||Bipolar Disorder and drug treatments|
|1st August||Legal responsibilities for Schedule 8 medications: a nurse’s perspective|
|1st September||The role of surgical antibiotic prophylaxis|
|1st October||Medications used as mood stabilisers|
|1st November||Minimising harm related to opioid medications|
|1st December||The importance of administering Parkinson’s disease medications on time|